lcampillos commited on
Commit
449e0e0
·
1 Parent(s): c6f7e16

Update README.md

Browse files
Files changed (1) hide show
  1. README.md +24 -28
README.md CHANGED
@@ -1,7 +1,7 @@
1
  ---
2
  license: cc-by-4.0
3
  ---
4
- # Dataset Card for [Dataset Name]
5
 
6
  ## Table of Contents
7
  - [Table of Contents](#table-of-contents)
@@ -33,7 +33,6 @@ license: cc-by-4.0
33
  - **Homepage:** http://www.lllf.uam.es/ESP/nlpmedterm_en.html
34
  - **Repository:** http://www.lllf.uam.es/ESP/nlpdata/wp2/CT-EBM-SP.zip
35
  - **Paper:** Campillos-Llanos, L., Valverde-Mateos, A., Capllonch-Carrión, A., & Moreno-Sandoval, A. (2021). A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine. BMC medical informatics and decision making, 21(1), 1-19
36
- - **Leaderboard:**
37
  - **Point of Contact:** leonardo.campillos AT gmail.com
38
 
39
  ### Dataset Summary
@@ -57,9 +56,9 @@ If you use the CT-EBM-ES resource, please, cite as follows:
57
  }
58
  ```
59
 
60
- ### Supported Tasks and Leaderboards
61
 
62
- [More Information Needed]
63
 
64
  ### Languages
65
 
@@ -68,47 +67,44 @@ Spanish
68
  ## Dataset Structure
69
 
70
  ### Data Instances
 
 
 
 
 
 
71
 
72
- [More Information Needed]
73
-
74
- ### Data Fields
75
-
76
- [More Information Needed]
77
 
78
  ### Data Splits
79
 
80
- [More Information Needed]
 
 
81
 
82
  ## Dataset Creation
83
 
84
- ### Curation Rationale
85
-
86
- [More Information Needed]
87
-
88
  ### Source Data
89
 
90
  #### Initial Data Collection and Normalization
91
 
92
- [More Information Needed]
93
-
94
- #### Who are the source language producers?
95
-
96
- [More Information Needed]
97
-
98
  ### Annotations
99
 
100
- #### Annotation process
101
 
102
- [More Information Needed]
 
 
103
 
104
- #### Who are the annotators?
105
 
106
- [More Information Needed]
107
 
108
- ### Personal and Sensitive Information
109
 
110
- [More Information Needed]
111
 
112
- ## Considerations for Using the Data
 
 
113
 
114
- ### Social Impact of Dataset
 
1
  ---
2
  license: cc-by-4.0
3
  ---
4
+ # Dataset Card for [CT-EBM-ES (Clinical Trials for Evidence-based Medicine in Spanish)]
5
 
6
  ## Table of Contents
7
  - [Table of Contents](#table-of-contents)
 
33
  - **Homepage:** http://www.lllf.uam.es/ESP/nlpmedterm_en.html
34
  - **Repository:** http://www.lllf.uam.es/ESP/nlpdata/wp2/CT-EBM-SP.zip
35
  - **Paper:** Campillos-Llanos, L., Valverde-Mateos, A., Capllonch-Carrión, A., & Moreno-Sandoval, A. (2021). A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine. BMC medical informatics and decision making, 21(1), 1-19
 
36
  - **Point of Contact:** leonardo.campillos AT gmail.com
37
 
38
  ### Dataset Summary
 
56
  }
57
  ```
58
 
59
+ ### Supported Tasks
60
 
61
+ Medical Named Entity Recognition
62
 
63
  ### Languages
64
 
 
67
  ## Dataset Structure
68
 
69
  ### Data Instances
70
+ 292 173 tokens
71
+ 46 699 entities of the following medical UMLS semantic groups:
72
+ - ANAT: 6728 entities
73
+ - CHEM: 9224 entities
74
+ - DISO: 13 067 entities
75
+ - PROC: 17 680 entities
76
 
 
 
 
 
 
77
 
78
  ### Data Splits
79
 
80
+ Train: 175 203 tokens, 28 101 entities
81
+ Development: 58 670 tokens, 9629 entities
82
+ Test: 58 300 tokens, 8969 entities
83
 
84
  ## Dataset Creation
85
 
 
 
 
 
86
  ### Source Data
87
 
88
  #### Initial Data Collection and Normalization
89
 
 
 
 
 
 
 
90
  ### Annotations
91
 
92
+ #### Who are the annotators?
93
 
94
+ - Leonardo Campillos-Llanos, Computational Linguist, Consejo Superior de Investigaciones Científicas
95
+ - Adrián Capllonch-Carrión, Medical Doctor, Centro de Salud Retiro, Hospital Universitario Gregorio Marañón
96
+ - Ana Valverde-Mateos, Medical Lexicographist, Spanish Royal Academy of Medicine
97
 
98
+ ## Considerations for Using the Data
99
 
100
+ Disclosure: This dataset is under development and needs to be improved. It should not be used for medical decision making without human assistance and supervision.
101
 
102
+ This resource is intended for a generalist purpose, and may have bias and/or any other undesirable distortions.
103
 
104
+ The owner or creator of the models will in no event be liable for any results arising from the use made by third parties of this dataset.
105
 
106
+ Descargo de responsabilidad: Este conjunto de datos se encuentra en desarrollo y no debe ser empleada para la toma de decisiones médicas
107
+
108
+ La finalidad de este modelo es generalista, y puede tener sesgos y/u otro tipo de distorsiones indeseables.
109
 
110
+ El propietario o creador de los modelos de ningún modo será responsable de los resultados derivados del uso que las terceras partes hagan de estos datos.